ÂÜÀòÂÒÂ×

Dariusz Wodziak has worked in a variety of roles since 2009. From 2009 to 2010, they were a Research Assistant at the Regenerative Science Institute as part of an RSI Fellowship, where they were introduced to an academic research environment and practiced molecular biology techniques. From 2009 to 2011, they were a Research Assistant at the Sibley Lab, Stanford School of Medicine, where they investigated the role of single nucleotide polymorphisms in temporal lactase expression, trained in animal husbandry and procedures, and bred and maintained a mouse colony. From 2010 to 2011, they were a Research Assistant at Georgetown University, where they researched the inhibitory effects of green and black tea on acrolein, reorganized and catalogued paraffin tissue blocks and histological slides, and analyzed oral samples using immunofluorescence staining. From 2011 to 2015, they were a Life Science Technician at Stanford University School of Medicine, where they utilized established injury models, was responsible for breeding, genotyping, and maintaining a transgenic mouse colony, and examined Agr2 activity using various immunocytochemical and immunohistochemical techniques. From 2015 to 2017, they were a Research Associate at Theranos. From 2017 to 2019, they were a Senior Research Associate, Research Associate II, and Research Associate at Casebia Therapeutics. Since 2019, they have been a Senior Scientist, Scientist, and Associate Scientist at Earli Inc.

Dariusz Wodziak attended Stanford University from 2007 to 2011, where they earned a Bachelor of Science in Biology.